March 10, 2020 / 8:17 PM / 20 days ago

BRIEF-Satsuma Pharmaceuticals Posts Quarterly Loss Per Share Of $0.62

March 10 (Reuters) - Satsuma Pharmaceuticals Inc:

* SATSUMA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT BUSINESS RESULTS

* Q4 LOSS PER SHARE $0.62

* ON TRACK TO ANNOUNCE TOPLINE DATA IN SECOND HALF OF 2020 FROM PHASE 3 EMERGE™ EFFICACY TRIAL EVALUATING STS101

* CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $117.9 MILLION AT END OF 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below